Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy

Documenti analoghi

• M2 Macrophage‐Derived Exosomes Inhibiting Neutrophil Extracellular Traps for Ischemic Stroke Therapy
  di: Zhenhua Wang, et al.
  Pubblicazione: (2024)
• DNase1 Mimic TMNCs Disrupt Neutrophil Extracellular Traps and Free Radical Circulation for Ischemic Stroke Therapy
  di: Jiachen Sun, et al.
  Pubblicazione: (2025)
• Neutrophil‐to‐Lymphocyte Ratio as an Independent Predictor of Adverse Short‐Term Functional Outcomes After Reperfusion Therapy in Acute Ischemic Stroke
  di: Jun‐ying Li, et al.
  Pubblicazione: (2025)
• Omics‐Enhanced Nanomedicine for Cancer Therapy
  di: Lin Qi, et al.
  Pubblicazione: (2024)
• Association of Neutrophil Percentage‐to‐Albumin Ratio With White Matter Hyperintensities in Patients With Ischemic Stroke
  di: Xiuqun Gong, et al.
  Pubblicazione: (2025)